Schott and Xinkang joint venture

Schott and Zhejiang Xinkang Pharmaceutical Glass Co., Ltd. will establish a pharmaceutical packaging joint venture in China, in which Schott will own the majority of shares. The new company will supply the Chinese pharmaceutical market with high-quality glass pharmaceutical packaging.

German technology group Schott and Chinese company Zhejiang Xinkang Pharmaceutical Glass Co., Ltd. have signed an agreement to establish a pharmaceutical packaging joint venture in China. Schott will own the majority of shares of the new company that will supply the fast-growing Chinese pharmaceutical market with high-quality pharmaceutical packaging products made of glass. The closing of the joint venture is subject to customary closing conditions.
With this joint venture, Schott will be strengthening its position in the important growth market of China and continuing its expansion in the emerging pharmaceutical markets. Schott Pharmaceutical Systems already operates manufacturing facilities in countries such as Brazil, Russia and India. The joint enterprise will manufacture at both Schott’s existing site in Suzhou, Jiangsu Province and in Jinyun, Zhejiang Province.